Slideshow
Author(s):
These technologies show promise in predicting dementia years before clinical symptoms develop; diagnosing concussion and other brain injuries; and more.
Ecopipam Meets Primary and Secondary End Points in Phase 3 Study for Tourette Syndrome
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
This Week on NeurologyLive® — February 24, 2025
Neurology Unwrapped: 2024’s Most Intriguing Conversations
M1 Modulatory TAK-091 Improves Cognition in Parkinson Disease, Study Shows
Exciting Innovations in Neurology to Come in 2025: Insights From Baptist Health